DG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0) (BioCAD00000020912)

blood feces all tissues

Metabolite Card

Formula: C39H66O5 (614.491)
SMILES: [H][C@](CO)(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC

Synonyms [en]

DG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0); DG(36:5); (2S)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate; DAG(14:0/22:5); DG(14:0_22:5); 1-tetradecanoyl-2-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycerol

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

DG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0). 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000020912). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

DG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of docosapentaenoic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the docosapentaenoic acid moiety is derived from fish oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

Entity Information

DBLinks

Other DBLinks
  • PubChem: 53477968
  • ChEBI: ChEBI:88791
  • HMDB: HMDB0007033
  • HMDB: HMDB07033
  • LipidMaps: LMGL02010400
  • Metlin: METLIN_58668
  • Coconut NaturalProduct: CNP0334068.1
  • Coconut NaturalProduct: CNP0334068.2

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0071308 Phosphatidylethanolamine Biosynthesis PE(14:0/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0073077 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0086756 Phosphatidylcholine Biosynthesis PC(14:0/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0088342 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:0)
PathBank:SMP0016871 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/16:0)
PathBank:SMP0016875 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:0)
PathBank:SMP0016879 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
PathBank:SMP0016883 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
PathBank:SMP0016887 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
PathBank:SMP0016891 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
PathBank:SMP0016895 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0064328 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0073080 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
PathBank:SMP0088341 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0016870 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/15:0)
PathBank:SMP0016874 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:0)
PathBank:SMP0016878 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
PathBank:SMP0016882 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
PathBank:SMP0016886 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
PathBank:SMP0016890 De Novo Triacylglycerol Biosynthesis TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
View All Pathways